1
TO DOWNLOAD A COPY OF THIS POSTER, VISIT WWW.WATERS.COM/POSTERS ©2019 Waters Corporation Targeted Multi-OMICS: Rapid Plasma Profiling of a Bladder and Lung Cancer Human Cohort Sarah Lennon, Billy Joe Molloy Waters Corporation, Wilmslow, United Kingdom TARGETED MULTI-OMICS WORKFLOW Figure 4: Peak areas for the spiked amino acid standard (valine d8) for all samples. The overall median coefficient of variation was observed to be 5%. Figure 3: Box and whisker plot representing the distribution of the peak area coefficients of variation (%CV) across the quality control samples for the 128 detected compounds in plasma. Figure 1: The Waters Single Platform Targeted OMICS Workflow. (MetaboQuan-R) Plasma samples are prepared using various sample preparation methods before being analysed consecutively on a single LC/MS platform. After data processing using Skyline and TargetLynx, the semi- quantitative data is statistically analysed using MetaboAnalyst. Figure 6: Pair-wise comparisons of 20 acylcarnitines (t-test, FDR cut-off value = 0.01). The pink dots represent significantly different acylcarnitines between the two conditions. Octanoyl carnitine (C8:1) was shown to be under-expressed in bladder cancer subjects. The statistical differentiation of acylcarnitine markers for lung cancer was less conclusive. LEARN MORE @ WWW.WATERS.COM/TARGETEDOMICS Figure 5: Pair-wise comparisons of 28 amino acids (t-test, FDR cut-off value = 0.01). The pink dots represent significantly different amino acids between the two conditions. Sarcosine was found to be over expressed for both bladder and lung cancer subjects. AMINO ACIDS ACYLCARNITINES PROTEINS Figure 7: Volcano plot highlighting potential proteins of interest (pink dots) when comparing bladder cancer vs. control and lung cancer vs. control. Median = Median = Median = FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES AMINO ACIDS ACYLCARNITINES PROTEINS Figure 2: representative chromatograms demonstrating separations achieved for MetaboQuan-R methods using the same Mobile Phase and UPLC Column

Sarah Lennon, Billy Joe Molloy Waters Corporation, Wilmslow, … · 2019. 10. 31. · Sarah Lennon, Billy Joe Molloy Waters Corporation, Wilmslow, United Kingdom TART MULTI-OMIS WORKLOW

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Sarah Lennon, Billy Joe Molloy Waters Corporation, Wilmslow, … · 2019. 10. 31. · Sarah Lennon, Billy Joe Molloy Waters Corporation, Wilmslow, United Kingdom TART MULTI-OMIS WORKLOW

TO DOWNLOAD A COPY OF THIS POSTER, VISIT WWW.WATERS.COM/POSTERS ©2019 Waters Corporation

Targeted Multi-OMICS: Rapid Plasma Profiling of a Bladder and Lung

Cancer Human Cohort Sarah Lennon, Billy Joe Molloy

Waters Corporation, Wilmslow, United Kingdom

TARGETED MULTI-OMICS WORKFLOW

Figure 4: Peak areas for the spiked amino acid

standard (valine d8) for all samples. The overall

median coefficient of variation was observed to

be 5%.

Figure 3: Box and whisker plot representing the

distribution of the peak area coefficients of

variation (%CV) across the quality control

samples for the 128 detected compounds in

plasma.

Figure 1:

The Waters Single Platform Targeted OMICS Workflow. (MetaboQuan-R) Plasma samples are prepared using various sample preparation methods before being analysed consecutively on a single LC/MS platform. After data processing using Skyline and TargetLynx, the semi-quantitative data is statistically analysed using MetaboAnalyst.

Figure 6: Pair-wise comparisons of 20

acylcarnitines

(t-test, FDR cut-off value = 0.01). The pink dots

represent significantly different acylcarnitines between the two conditions.

Octanoyl carnitine (C8:1) was shown to be

under-expressed in bladder cancer subjects. The

statistical differentiation of acylcarnitine markers

for lung cancer was less conclusive.

LEARN MORE @ WWW.WATERS.COM/TARGETEDOMICS

Figure 5: Pair-wise comparisons of 28 amino

acids (t-test, FDR cut-off value = 0.01). The pink

dots represent significantly different amino acids

between the two conditions. Sarcosine was found to be over expressed for both

bladder and lung cancer subjects.

AMINO ACIDS ACYLCARNITINES PROTEINS

Figure 7: Volcano plot highlighting potential proteins of interest (pink dots) when comparing bladder cancer vs. control and lung cancer vs. control.

Median = Median = Median =

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES

AMINO ACIDS ACYLCARNITINES PROTEINS

Figure 2: representative chromatograms demonstrating separations achieved for MetaboQuan-R methods using the same Mobile Phase and UPLC Column